Results 141 to 150 of about 567,668 (313)

D4 dopamine receptor high-resolution structures enable the discovery of selective agonists

Science, 2017
Sheng Wang, Daniel Wacker, A. Levit, T. Che, Robin M. Betz, J. McCorvy, A. Venkatakrishnan, Xi Ping Huang, R. Dror, B. Shoichet, B. Roth   +10 more
semanticscholar   +1 more source

Is there a role for cannabidiol in obesity, metabolic syndrome and binge eating?

British Journal of Pharmacology, EarlyView.
Cannabidiol (CBD) is one of the most abundant phytocannabinoids isolated from the Cannabis sativa plant. CBD is a lipophilic, non‐intoxicating substance that differently from Δ9‐tetrahydrocannabinol (Δ9‐THC) does not present the typical profile of a drug of abuse.
Luca Botticelli, Emanuela Micioni Di Bonaventura, Giacomo Einaudi, Gustavo Provensi, Alessia Costa, Claudio D'Addario, Carlo Cifani, Maria Vittoria Micioni Di Bonaventura   +7 more
wiley   +1 more source

Quantitative Evaluation of Pupil Responses in Patients with Prolactinomas Being Treated with Dopamine Agonists. [PDF]

Neuroophthalmology, 2022
Ava S, Hazar L, Karahan M, Erdem S, Dursun ME, Pekkolay Z, Keklikçi U.   +6 more
europepmc   +1 more source

Dopamine agonists for the treatment of cocaine dependence.

Cochrane Database of Systematic Reviews, 2015
S. Minozzi, L. Amato, P. Pani, R. Solimini, S. Vecchi, F. De Crescenzo, P. Zuccaro, M. Davoli   +7 more
semanticscholar   +1 more source

Sex‐specific impact of repeated adolescent vapour exposure to JWH‐018 on dopamine response, behaviour and pharmacokinetics across adolescence and adulthood

British Journal of Pharmacology, EarlyView.
Abstract Background and Purpose Alarming trends show that vaping e‐cigarettes containing synthetic cannabinoid receptor agonists, such as JWH‐018, is increasing among youth. However, the effects of these trends are unclear in both sexes. We therefore characterized the neuropharmacological effects of adolescent JWH‐018 inhalation in male and female rats.
Nicholas Pintori, Cristina Manis, Enrica Spano, Nicola Simola, Alessandro Ieraci, Pierluigi Caboni, Gaetano Di Chiara, Maria Antonietta De Luca   +7 more
wiley   +1 more source

Bivalent dopamine agonists with co-operative binding and functional activities at dopamine D2 receptors, modulate aggregation and toxicity of alpha synuclein protein. [PDF]

Bioorg Med Chem, 2023
Dinda B, Das B, Biswas S, Sharma H, Armstrong C, Yedlapudi D, Antonio T, Reith M, Dutta AK.   +8 more
europepmc   +1 more source

Hyperprolactinaemia resistant to dopamine agonist due to an ectopic source of prolactin arising from a Uterine Tumour Resembling Ovarian Sex Cord Tumours (UTROCST)

, 2019
Sobia Arshad, Mohammed Bakhit, John Bidmead, Dorothy Lewis, Salvador J. Díaz‐Cano, Simon Aylwin, Wajman Delane   +6 more
openalex   +2 more sources

3,4‐Methylenedioxymethamphetamine (MDMA) does not induce robust psychomotor activation and 50‐kHz ultrasonic vocalisations in tryptophan hydroxylase 2 (Tph2)‐deficient rats lacking serotonin in the central nervous system

British Journal of Pharmacology, EarlyView.
Background and Purpose 3,4‐Methylenedioxymethamphetamine (MDMA), commonly known as ecstasy, is a psychostimulant with entactogenic properties and known to induce arousal and euphoria. As an amphetamine derivate, MDMA acts on the monoamine systems in the brain and stimulates release of dopamine (DA), noradrenaline (NA) and serotonin (5‐HT), yet their ...
Tianhua Wang, Rainer K. W. Schwarting, Markus Wöhr   +2 more
wiley   +1 more source

Othello Syndrome Induced by Dopamine Agonists in Parkinson's Disease: A Case Report. [PDF]

Case Rep Psychiatry
Ahmed GU, Ahmed HU, Raza AA, Samadi A.
europepmc   +1 more source

Are dopamine agonists still the first-choice treatment for prolactinoma in the era of endoscopy? A systematic review and meta-analysis. [PDF]

Chin Neurosurg J, 2022
Cai X, Zhu J, Yang J, Tang C, Cong Z, Ma C.   +5 more
europepmc   +1 more source